Lung carcinogenesis from chronic obstructive pulmonary disease: Characteristics of lung cancer from COPD and contribution of signal transducers and lung stem cells in the inflammatory microenvironment

General Thoracic and Cardiovascular Surgery

Volumn 62, Issue 7, 2014, Pages 415-421

  Sekine, Yasuo ^a   Hata, Atsushi ^a   Koh, Eitetsu ^a   Hiroshima, Kenzo ^a  

^a Tokyo Women s Medical University   (Japan)

Author keywords

Cancer stem cells; Carcinogenesis; Chronic obstructive pulmonary disease; Lung cancer; Signal transducers

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT3 PROTEIN; TOXIC GAS; TRANSCRIPTION FACTOR;

CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER STEM CELL; CANCER SURGERY; CANCER THERAPY; CARDIOPULMONARY FUNCTION; CELL ACTIVATION; CELL DAMAGE; CELL DEATH; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; LUNG ALVEOLUS CELL; LUNG CANCER; LUNG CARCINOGENESIS; LUNG INJURY; LUNG LAVAGE; MOLECULAR BIOLOGY; MOLECULARLY TARGETED THERAPY; PARACRINE SIGNALING; PATHOGENESIS; PNEUMONIA; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOGENESIS; CELL DIFFERENTIATION; DISEASE PROGRESSION; HUMANS; INFLAMMATION; LUNG; LUNG NEOPLASMS; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIGNAL TRANSDUCTION; SMOKING; STEM CELLS;

EID: 84904746763     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-014-0386-x     Document Type: Review

References (43)

1. The top 10 causes of death, programmes and projects in World Health Organization (WHO). http://www.who.int/mediacentre/factsheets/fs310/en/index. html updated: 5 Jan 2014.
2. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One. 2009; 4: e7380. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0007380 updated: 5 Jan 2014.
3. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176:285-90. (Pubitemid 47195879)
4. Sekine Y, Katsura H, Koh E, Hiroshima K, Fujisawa T. Early detection of COPD is important for lung cancer surveillance. Eur Respir J. 2012;39(5):1230-40.
5. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34:380-6.
6. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178:738-44.
7. Congleton J, Muers MF. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med. 1995;89:291-6.
8. Kurishima K, Satoh H, Ishikawa H, Yamashita YT, Homma T, Ohtsuka M, et al. Lung cancer patients with chronic obstructive pulmonary disease. Oncol Rep. 2001;8:63-5. (Pubitemid 33758201)
9. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987;106:512-8. (Pubitemid 17095034)
10. Vineis P, Airoldi L, Veglia F, Olgiati L, Pastorelli R, Autrup H, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ. 2005;330:277.
11. de Torres JP, Marín JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, et al. Lung cancer in patients with chronic obstructive pulmonary disease-incidence and predicting factors. Am J Respir Crit Care Med. 2011;184(8):913-9.
12. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245-57. (Pubitemid 44883863)
13. Sekine Y, Fujisawa T, Suzuki K, Tsutatani S, Kubota K, Ikegami H, et al. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba COPD lung cancer screening study group. Respirology. 2014;19(1):98-104.
14. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data from the first National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003;163:1475-80. (Pubitemid 36758921)
15. Calabrò E, Randi G, La Vecchia C, Sverzellati N, Marchianò A, Villani M, et al. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J. 2010;35:146-51.
16. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomark Prev. 2003;12:689-98. (Pubitemid 36993157)
17. Cohen BH. Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol. 1980;112:274-88. (Pubitemid 10018966)
18. Coté ML, Kardia SL, Wenzlaff AS, Ruckdeschel JC, Schwartz AG. Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA. 2005;293:3036-42. (Pubitemid 40965074)
19. Schwartz AG, Ruckdeschel JC. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:16-22. (Pubitemid 43069784)
20. Sekine Y, Suzuki H, Yamada Y, Koh E, Yoshino I. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection. Thorac Cardiovasc Surg. 2013;61(2):124-30.
21. Kondo R, Yoshida K, Eguchi T, Kobayashi N, Saito G, Hamanaka K, et al. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases. Eur J Cardiothorac Surg. 2011;40(6):1439-43.
22. Sekine Y, Kesler KA, Behnia M, Brooks-Brunn JA, Sekine E, Brown JW. COPD may increases the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer. Chest. 2001;120:1783-90.
23. Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and long term survival in patients with surgical treatment for NSCLC. Lung Cancer. 2002;37:95-101. (Pubitemid 34621464)
24. Sekine Y, Yamada Y, Chiyo M, Iwata T, Nakajima T, Yasufuku K, et al. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg. 2007;84:946-50. (Pubitemid 47285026)
25. Nakajima T, Sekine Y, Yamada Y, Suzuki H, Yasufuku K, Yoshida S, et al. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD. Thorac Cardiovasc Surg. 2009;57:339-42.
26. Sekine Y, Sakairi Y, Yoshino M, Koh E, Hata A, Suzuki H, et al. The impact of combined pulmonary fibrosis and chronic obstructive pulmonary disease on long-term survival after lung cancer surgery. Thorac Cardiovasc Surg. 2014 (in press). doi: 10.1055/s-0033-1363478.
27. Sekine Y, Chiyo M, Iwata T, Yasufuku K, Furukawa S, Iizasa T, et al. Perioperative rehabilitation and physiotherapy for lung cancer patients with chronic obstructive pulmonary disease. Jpn J Thorac Cardiovasc Surg. 2005;53:237-43. (Pubitemid 40806016)
28. Suzuki H, Sekine Y, Nakajima T, Yasufuku K, Yoshida S, Suzuki M, et al. Efficacy of peri-operative administration of long-acting bronchodilator on post-operative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease - preliminary results of a randomized control study. Surgery Today. 2010;40:923-30.
29. Sekine Y, Iwata T, Chiyo M, Yasufuku K, Motohashi S, Yoshida S, et al. Minimal alteration of pulmonary function after lobectomy in lung cancer patients with COPD. Ann Thorac Surg. 2003;76:356-61. (Pubitemid 36960568)
30. Yamada Y, Sekine Y, Suzuki H, Iwata T, Chiyo M, Nakajima T, et al. Trends of bacterial colonisation and the risk of postoperative pneumonia in lung cancer patients with chronic obstructive pulmonary disease. Eur J Cardiothorac Surg. 2010;37:752-7.
31. Sekine Y, Koh E, Oishi H, Miwa M. A simple and effective technique for identification of intersegmental planes by infrared thoracoscopy after transbronchial injection of indocianine green. J Thorac Cardiovasc Surg. 2012;143(6):1330-5.
32. Nakao M, Yoshida J, Goto K, Ishii G, Kawase A, Aokage K, et al. Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules. J Thorac Oncol. 2012;7(10):1563-6.
33. Brody JS, Spira A. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc. 2006;3(6):535-7. (Pubitemid 44285546)
34. Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81(4):265-84.
35. Weiss J, Sos ML, Seidel D, Peifer M, Zander T, Heuckmann JM, et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med. 2010;2(62):62ra93.
36. Vermaelen K, Brusselle G. Exposing a deadly alliance: novel insights into the biological links between COPD and lung cancer. Pulm Pharmacol Ther. 2013;26(5):544-54.
37. Houghton AM, Mouded M, Shapiro SD. Common origins of lung cancer and COPD. Nat Med. 2008;14:1023-4.
38. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005;121:823-35. (Pubitemid 40806415)
39. Kratz JR, Yagui-Beltrán A, Jablons DM. Cancer stem cells in lung tumorigenesis. Ann Thorac Surg. 2010;89(6):S2090-5.
40. Alamgeer M, Peacock CD, Matsui W, Ganju V, Watkins DN. Cancer stem cells in lung cancer: evidence and controversies. Respirology. 2013;18(5):757-64.
41. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21(1):11-9.
42. Castaño Z, Fillmore CM, Kim CF, McAllister SS. The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells. Semin Cancer Biol. 2012;22(5-6):462-70.
43. Young RP, Hopkins RJ. How the genetics of lung cancer may overlap with COPD. Respirology. 2011;16(7):1047-55.